pBAMD1-2 Citations (3)
Originally described in: New transposon tools tailored for metabolic engineering of gram-negative microbial cell factories.Martinez-Garcia E, Aparicio T, de Lorenzo V, Nikel PI Front Bioeng Biotechnol. 2014 Oct 28;2:46. doi: 10.3389/fbioe.2014.00046. eCollection 2014. PubMed Journal
Articles Citing pBAMD1-2
| Articles |
|---|
| Engineering Gram-Negative Microbial Cell Factories Using Transposon Vectors. Martinez-Garcia E, Aparicio T, de Lorenzo V, Nikel PI. Methods Mol Biol. 2017;1498:273-293. PubMed |
| Implication of the Type III Effector RipS1 in the Cool-Virulence of Ralstonia solanacearum Strain UW551. Schachterle JK, Huang Q. Front Plant Sci. 2021 Jul 22;12:705717. doi: 10.3389/fpls.2021.705717. eCollection 2021. PubMed |
Cross-kingdom expression of synthetic genetic elements promotes discovery of metabolites in the human microbiome.
Patel JR, Oh J, Wang S, Crawford JM, Isaacs FJ.
Cell. 2022 Apr 28;185(9):1487-1505.e14. doi: 10.1016/j.cell.2022.03.008. Epub 2022 Apr 1.
PubMed
Associated Plasmids |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.